Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain

NCT02959996 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02959996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02959996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine at Cesarean Delivery to Decrease Post-operative Pain
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
March 8, 2017
Completion date
November 3, 2017
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative